HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hair Fairies tutors parents

This article was originally published in The Rose Sheet

Executive Summary

Sensitive to families' tight budgets in a trying economy, Los Angeles-based chain of upscale kid-friendly salons will launch a do-it-yourself lice removal video guide on its Web site Feb. 3. "When a client is treated in-store," Hair Fairies says, "there is a 100% service guarantee. But in the current economic climate, many families are wary of the additional out-of-pocket expense involved in visiting a head lice salon." A written step-by-step tutorial already is available at HairFairies.com, with links to purchase the "all-natural," FDA-approved Hair Fairies products used in the process. A home kit consisting of Nit-Zapping Clenz Shampoo, Clenz Cream and a nit comb costs $45. Company founder Maria Botham appeared on ABC's "Good Morning America" Jan. 26 to discuss Hair Fairies' salon services, calling the company "the Starbucks of head-lice removal." Concerned parents also are invited to call the brand's free Head Lice Hotline. Fairy Tales Hair Care is another company offering head-lice treatments touted as natural, non-toxic alternatives to harsher insecticides on the market (1"The Rose Sheet" May 18, 2009)

You may also be interested in...



Fairy Tales’ Rosemary Repel Line Offers Natural, Effective Lice Prevention

Fairy Tales Hair Care heads into summer camp season with independent, in vitro study results that suggest its all-natural Rosemary Repel line is more than 92 percent effective at preventing lice infestation

Chinese Firms Up Their Game In Novel Flu Antiviral Development

Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.

Quotable: Words Of Wisdom From Our Recent APAC Coverage

Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016704

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel